Answers are grounded in this paper and cite their sources.
Metformin (biguanide) is a widely used drug for treating diabetes mellitus type 2. It has been used for 60 years and is a highly effective anti-hyperglycaemic drug. 1 Extensive research has been conducted on the drug's action mechanism in order to explain its effects on gluconeogenesis, protein metabolism, fatty acid oxidation, oxidative stress, glucose uptake, autophagia, and pain, among other processes.Some mechanisms were not identified until the late 1990s and early 2000s.Metformin induces beneficial effects in patients with diabetes by activating adenosine monophosphateactivated protein kinase (AMPK).Two kinases are responsible for AMPK activation: liver kinase B1 (LKB1) and calcium/ calmodulin-dependent protein kinase II (CaMKII).Once activated, AMPK inhibits the mechanistic target of rapamycin complex 1 (mTORC1), which includes the mammalian target of rapamycin (mTOR).The TOR protein family has pleiotropic functions and participates in the regulation of mRNA transcription and translation in response to intracellular concentrations of amino acids and other essential nutrients.2 AMPK is an enzyme that includes three subunits: a catalytic subunit (α) and two non-catalytic subunits (β and γ).It participates in cellular homeostasis and maintains cell ⁎ Corresponding author.
No takes yet. Share an insight, caveat, or question.
Montero et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: